Trials / Completed
CompletedNCT07216313
A Drug-Drug Interaction Study of Denifanstat and Resmetirom in Healthy Adult Participants
A Phase 1, Open-Label Study to Evaluate the Mutual Drug-Drug Interaction Potential Between Denifanstat and Resmetirom in Healthy Adult Participants
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Sagimet Biosciences Inc. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This is an open-label, 2-cohort study to evaluate the mutual DDI potential between denifanstat and resmetirom in healthy adult participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Denifanstat | Once daily |
| DRUG | Resmetirom | Once daily |
Timeline
- Start date
- 2025-09-30
- Primary completion
- 2025-10-20
- Completion
- 2025-10-20
- First posted
- 2025-10-14
- Last updated
- 2026-01-23
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07216313. Inclusion in this directory is not an endorsement.